The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
1 tablet contains cinnarizine, in terms of 100% of the substance - 75 mg.
Symptomatic treatment: labyrinthine disorders including vertigo, tinnitus, nystagmus, nausea and vomiting; cerebrovascular disorders, including dizziness, tinnitus (tintos), headache of vascular origin, irritability, impairment of memory and ability to concentrate; peripheral vascular disorders, including Raynaud's disease, acrocyanosis, intermittent claudication, trophic disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, a sensation of cold in the extremities.
If you have information about any adverse effects or other drug-related problems, please fill in the form